Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer

NCT06368141 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer

Interventions

DRUG: Serplulimab
DRUG: Capecitabine
DRUG: Oxaliplatin

Sponsor

Ruijin Hospital